Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

1.

Sequencing rare and common APOL1 coding variants to determine kidney disease risk.

Limou S, Nelson GW, Lecordier L, An P, O'hUigin CS, David VA, Binns-Roemer EA, Guiblet WM, Oleksyk TK, Pays E, Kopp JB, Winkler CA.

Kidney Int. 2015 May 20. doi: 10.1038/ki.2015.151. [Epub ahead of print]

PMID:
25993319
2.

ALDsuite: Dense marker MALD using principal components of ancestral linkage disequilibrium.

Johnson RC, Nelson GW, Zagury JF, Winkler CA.

BMC Genet. 2015 Mar 7;16(1):23. doi: 10.1186/s12863-015-0179-y.

3.

APOL1 toxin, innate immunity, and kidney injury.

Limou S, Dummer PD, Nelson GW, Kopp JB, Winkler CA.

Kidney Int. 2015 Apr 8. doi: 10.1038/ki.2015.109. [Epub ahead of print]

PMID:
25853332
4.

Amplified electron transfer at poly-ethylene-glycol (PEG) grafted electrodes.

Hotchen CE, Maybury IJ, Nelson GW, Foord JS, Holdway P, Marken F.

Phys Chem Chem Phys. 2015 Apr 21;17(17):11260-8. doi: 10.1039/c5cp01244a.

PMID:
25836325
5.

APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.

Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, Limou S, Sezgin E, Nelson GW, Fogo AB, Goetsch S, Kopp JB, Winkler CA, Naicker S.

J Am Soc Nephrol. 2015 Mar 18. pii: ASN.2014050469. [Epub ahead of print]

PMID:
25788523
6.

APOL1 kidney risk alleles: population genetics and disease associations.

Limou S, Nelson GW, Kopp JB, Winkler CA.

Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33. doi: 10.1053/j.ackd.2014.06.005. Review.

PMID:
25168832
7.

Hydrothermal conversion of one-photon-fluorescent poly(4-vinylpyridine) into two-photon-fluorescent carbon nanodots.

Lawrence K, Xia F, Arrowsmith RL, Ge H, Nelson GW, Foord JS, Felipe-Sotelo M, Evans ND, Mitchels JM, Flower SE, Botchway SW, Wolverson D, Aliev GN, James TD, Pascu SI, Marken F.

Langmuir. 2014 Oct 7;30(39):11746-52. doi: 10.1021/la404866s. Epub 2014 Mar 21.

PMID:
24621350
8.

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort.

Haemophilia. 2013 Jan;19(1):113-8. doi: 10.1111/hae.12004. Epub 2012 Sep 7.

9.

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB; SK Investigators.

Kidney Int. 2013 Jan;83(1):114-20. doi: 10.1038/ki.2012.263. Epub 2012 Jul 25.

10.

HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.

Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, Lucas GM, Nelson GW, Warner AC, Winkler CA, Kopp JB.

Kidney Int. 2012 Aug;82(3):338-43. doi: 10.1038/ki.2012.111. Epub 2012 Apr 11.

11.

Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia.

An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, Kirk GD, Troyer JL, Sezgin E, Buchbinder SP, Donfield S, Nelson GW, Winkler CA.

PLoS Genet. 2011 Oct;7(10):e1002328. doi: 10.1371/journal.pgen.1002328. Epub 2011 Oct 27.

12.

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA.

J Am Soc Nephrol. 2011 Nov;22(11):2129-37. doi: 10.1681/ASN.2011040388. Epub 2011 Oct 13.

13.

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.

Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW.

PLoS Genet. 2011 Jun;7(6):e1002150. doi: 10.1371/journal.pgen.1002150. Epub 2011 Jun 16.

14.

Genome-wide association study implicates PARD3B-based AIDS restriction.

Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, Li G, Pontius J, Tang M, An P, Winkler CA, Limou S, Le Clerc S, Delaneau O, Zagury JF, Schuitemaker H, van Manen D, Bream JH, Gomperts ED, Buchbinder S, Goedert JJ, Kirk GD, O'Brien SJ.

J Infect Dis. 2011 May 15;203(10):1491-502. doi: 10.1093/infdis/jir046.

15.

Enhanced TiO2 surface electrochemistry with carbonised layer-by-layer cellulose-PDDA composite films.

Vuorema A, Shariki S, Sillanpää M, Thielemans W, Nelson GW, Foord JS, Dale SE, Bending S, Marken F.

Phys Chem Chem Phys. 2011 May 28;13(20):9857-62. doi: 10.1039/c1cp20532c. Epub 2011 Apr 18.

PMID:
21499622
16.

Accounting for multiple comparisons in a genome-wide association study (GWAS).

Johnson RC, Nelson GW, Troyer JL, Lautenberger JA, Kessing BD, Winkler CA, O'Brien SJ.

BMC Genomics. 2010 Dec 22;11:724. doi: 10.1186/1471-2164-11-724.

17.

MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?

Kopp JB, Winkler CA, Nelson GW.

Semin Nephrol. 2010 Jul;30(4):409-17. doi: 10.1016/j.semnephrol.2010.06.007.

18.

The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR.

J Am Soc Nephrol. 2010 Sep;21(9):1422-6. doi: 10.1681/ASN.2010070730. Epub 2010 Aug 5. Review.

19.

Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR.

Science. 2010 Aug 13;329(5993):841-5. doi: 10.1126/science.1193032. Epub 2010 Jul 15.

20.

Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.

Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA.

PLoS One. 2010 Jul 9;5(7):e11474. doi: 10.1371/journal.pone.0011474.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk